Pain and emotional well-being outcomes in southwest oncology group-directed intergroup trial S0205: A phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer
Antineoplastic Combined Chemotherapy Protocols
Quality of Life
We observed palliated pain and improved well-being for patients on this trial. However, these improvements were similar in both treatment arms, suggesting that the addition of cetuximab did not contribute to improvement in these HRQL outcomes.